Jarryl D'Oyley 4/23/25 Jarryl D'Oyley 4/23/25 Kuano Featured in GeneOnline: Quantum Drug Discovery in Action Read More Jarryl D'Oyley 10/4/24 Jarryl D'Oyley 10/4/24 Kuano CTO discusses Validating in-silico drug design with Quantum and AI Read More Jarryl D'Oyley 8/30/24 Jarryl D'Oyley 8/30/24 Kuano makes significant strides towards novel bowel cancer therapy Read More Jarryl D'Oyley 8/23/24 Jarryl D'Oyley 8/23/24 Kuano CTO will be presenting at the Cambridge Cheminformatics Meeting Read More Jarryl D'Oyley 8/12/24 Jarryl D'Oyley 8/12/24 Kuano talked to Foresight about Quantum Computing for Drug Design Read More Jarryl D'Oyley 5/10/24 Jarryl D'Oyley 5/10/24 Kuano Welcomes Dr David Barrett as Scientific Advisory Board member Read More Jarryl D'Oyley 4/9/24 Jarryl D'Oyley 4/9/24 Kuano is delighted to welcome Augustin Amour to the company Read More Jarryl D'Oyley 3/13/24 Jarryl D'Oyley 3/13/24 Kuano is delighted to have recognised as one of the Top21 companies to watch in 2024 Read More Jarryl D'Oyley 2/29/24 Jarryl D'Oyley 2/29/24 The new EVP of Business Development is Cat Stace Read More Jarryl D'Oyley 2/20/24 Jarryl D'Oyley 2/20/24 Dr Ted Witek joins Kuano’s board of directors Read More Jarryl D'Oyley 2/16/24 Jarryl D'Oyley 2/16/24 Kuano has made the shortlist for the @cofinitive #21toWatch award. Read More Jarryl D'Oyley 12/15/23 Jarryl D'Oyley 12/15/23 Vid Stojevic, Kuano’s CEO is attending the J.P. Morgan Healthcare Conference Read More Jarryl D'Oyley 10/13/23 Jarryl D'Oyley 10/13/23 Mercia discusses why they invested in Kuano Read More Jarryl D'Oyley 9/26/23 Jarryl D'Oyley 9/26/23 "It's not just 3D simulation" - CEO discusses how investment will enable Kuano to transform computational drug design Read More Jarryl D'Oyley 9/12/23 Jarryl D'Oyley 9/12/23 Kuano raises £1.8M in seed funding round to accelerate quantum drug discovery. Read More Jarryl D'Oyley 7/14/23 Jarryl D'Oyley 7/14/23 Kuano has been featured by Oracle Read More Jarryl D'Oyley 3/16/23 Jarryl D'Oyley 3/16/23 Vid Stojevic, Kuano’s CEO is attending Bio-Europe Spring Read More Jarryl D'Oyley 2/16/23 Jarryl D'Oyley 2/16/23 Podcast: Kuano’s perspective on drug design Read More Jarryl D'Oyley 1/9/23 Jarryl D'Oyley 1/9/23 Awarded: Innovate UK funding to design a new generation of cancer drugs Read More David Wright 8/15/22 David Wright 8/15/22 The new Chief Operating Officer for Kuano is Denise Moody Read More Older Posts
Jarryl D'Oyley 4/23/25 Jarryl D'Oyley 4/23/25 Kuano Featured in GeneOnline: Quantum Drug Discovery in Action Read More
Jarryl D'Oyley 10/4/24 Jarryl D'Oyley 10/4/24 Kuano CTO discusses Validating in-silico drug design with Quantum and AI Read More
Jarryl D'Oyley 8/30/24 Jarryl D'Oyley 8/30/24 Kuano makes significant strides towards novel bowel cancer therapy Read More
Jarryl D'Oyley 8/23/24 Jarryl D'Oyley 8/23/24 Kuano CTO will be presenting at the Cambridge Cheminformatics Meeting Read More
Jarryl D'Oyley 8/12/24 Jarryl D'Oyley 8/12/24 Kuano talked to Foresight about Quantum Computing for Drug Design Read More
Jarryl D'Oyley 5/10/24 Jarryl D'Oyley 5/10/24 Kuano Welcomes Dr David Barrett as Scientific Advisory Board member Read More
Jarryl D'Oyley 4/9/24 Jarryl D'Oyley 4/9/24 Kuano is delighted to welcome Augustin Amour to the company Read More
Jarryl D'Oyley 3/13/24 Jarryl D'Oyley 3/13/24 Kuano is delighted to have recognised as one of the Top21 companies to watch in 2024 Read More
Jarryl D'Oyley 2/29/24 Jarryl D'Oyley 2/29/24 The new EVP of Business Development is Cat Stace Read More
Jarryl D'Oyley 2/20/24 Jarryl D'Oyley 2/20/24 Dr Ted Witek joins Kuano’s board of directors Read More
Jarryl D'Oyley 2/16/24 Jarryl D'Oyley 2/16/24 Kuano has made the shortlist for the @cofinitive #21toWatch award. Read More
Jarryl D'Oyley 12/15/23 Jarryl D'Oyley 12/15/23 Vid Stojevic, Kuano’s CEO is attending the J.P. Morgan Healthcare Conference Read More
Jarryl D'Oyley 10/13/23 Jarryl D'Oyley 10/13/23 Mercia discusses why they invested in Kuano Read More
Jarryl D'Oyley 9/26/23 Jarryl D'Oyley 9/26/23 "It's not just 3D simulation" - CEO discusses how investment will enable Kuano to transform computational drug design Read More
Jarryl D'Oyley 9/12/23 Jarryl D'Oyley 9/12/23 Kuano raises £1.8M in seed funding round to accelerate quantum drug discovery. Read More
Jarryl D'Oyley 3/16/23 Jarryl D'Oyley 3/16/23 Vid Stojevic, Kuano’s CEO is attending Bio-Europe Spring Read More
Jarryl D'Oyley 1/9/23 Jarryl D'Oyley 1/9/23 Awarded: Innovate UK funding to design a new generation of cancer drugs Read More
David Wright 8/15/22 David Wright 8/15/22 The new Chief Operating Officer for Kuano is Denise Moody Read More
